Trials / Terminated
TerminatedNCT00471744
HEAD-Study Optimizing the Treatment of Children With BECTS
HEAD-TO-HEAD Evaluation of the Antiepileptic Drugs Levetiracetam (LEV) vs. Sulthiame (STM) in a German Multi-Centre, Doubleblind Controlled Trial in Children With Benign Epilepsy With Centro-Temporal Spikes
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Ludwig-Maximilians - University of Munich · Academic / Other
- Sex
- All
- Age
- 6 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that Levetiracetam is as effective as Sulthiame in the treatment of children with BECTS. Patients entering the HEAD-Studie are either treated with Leveitracetam or Sulthiame over a 6 months period. Patients are equally randomised to one of the two treatment regimens. Administration of medication as blinded capsules.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Treatment with levetiracetam or sulthiame over a six-month period. |
Timeline
- Start date
- 2006-06-01
- Completion
- 2008-07-01
- First posted
- 2007-05-10
- Last updated
- 2009-01-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00471744. Inclusion in this directory is not an endorsement.